1 August

To continue one of today’s themes, on GLP-1 drugs. I asked my friend, one of the leading international specialists treating people with ongoing (often appalling) issues from Covid infections, about use of GLP-1 drugs to treat those patients. He said: “It’s extraordinary!!! The only thing I’ve seen that genuinely moves the needle. I’m abandoning many of my previous treatments…or slowly withdrawing them as I dial up the Mounjaro. It will stabilise many and provide meaningful protection from end-organ injury. Also (separately to Covid) a reduction of 40% in the prevalence of REM Behaviour Disorder.”